ClinConnect ClinConnect Logo
Search / Trial NCT03396094

Pre- and Apnoeic Oxygenation for RSI in ED

Launched by NATIONAL UNIVERSITY HOSPITAL, SINGAPORE · Jan 4, 2018

Trial Information

Current as of May 23, 2025

Completed

Keywords

High Flow Oxygenation, Rapid Sequence Intubation

ClinConnect Summary

Maintaining adequate oxygenation during rapid sequence intubation (RSI) is imperative to prevent peri-intubation adverse events that can lead to increased duration of hospital and intensive care unit stay, or prolonged vegetative state requiring long-term institutionalisation.

Preliminary data from our emergency department (ED) airway registry revealed that 15% of patients experienced desaturation during intubation despite employing current best practices during RSI. In this multicentre randomised controlled trial in the ED, we aim to test the hypothesis that use of humidified high flow ox...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult patients aged 21 years and above, who require RSI due to medical, surgical and traumatic conditions, in the Emergency Departments of NUH and Ng Teng Fong General Hospital (NTFGH)
  • Exclusion Criteria:
  • Patients with "do-not-resuscitate" orders
  • Crash, awake or delayed sequence intubations
  • Patients requiring non-invasive positive pressure ventilation
  • Cardiac arrest
  • Clinical suspicion or confirmed diagnosis of base of skull fractures or severe facial trauma that precludes nasal cannula placement
  • Vulnerable patient populations (e.g. pregnant women, prisoners)

About National University Hospital, Singapore

National University Hospital (NUH) in Singapore is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, NUH emphasizes a multidisciplinary approach, integrating cutting-edge medical research with high-quality patient care. The hospital collaborates with various stakeholders, including academic institutions and industry partners, to explore new therapies and improve treatment outcomes across a wide range of medical disciplines. Committed to ethical standards and patient safety, NUH plays a pivotal role in shaping the future of medicine in Singapore and beyond.

Locations

Singapore, , Singapore

Patients applied

0 patients applied

Trial Officials

Mui Teng Chua, MBBS, MPH

Principal Investigator

National University Hospital, Singapore

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials